Skip to content

Imax IMAX Net Investment in Lease And Financing Receivables, After Allowance For Credit Loss, Nonaccrual

Other financials

Income statement

See full
Revenue$81.4M-6.1%
Gross profit$45.8M-13.9%
Operating income$10.0M-40.5%
Net income$4.2M+81.6%
EPS (diluted)$0.07+75.0%

Balance sheet

See full
Cash & equivalents$146.0M+50.4%
Total debt$11.1M-6.7%
Total equity$335.5M+12.0%
Total assets$893.2M+5.3%

Cash flow

See full
Operating cash flow$4.0M-42.0%
CapEx$2.1M+29.6%
Free cash flow$1.9M-64.2%

Valuation

See full
Market cap$2.47B+46.9%
P/E67.3×+0.2×
P/S6.1×+1.4×

Profitability

See full
Gross margin59%+4.4pp
Operating margin19.1%+5.6pp
Net margin9.1%+2.1pp
FCF margin28.5%+6.3pp

Returns & leverage

See full
Return on equity11.6%+2.6pp
Debt / equity0.0×

Where this comes from

Reported directly by Imax in its filing.

Tagged under the XBRL concept imax:NetInvestmentInLeaseAndFinancingReceivablesAfterAllowanceForCreditLossNonaccrual.

The official record: Imax’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Imax's net investment in lease and financing receivables, after allowance for credit loss, nonaccrual.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Imax's net investment in lease and financing receivables, after allowance for credit loss, nonaccrual?
Imax (IMAX) reported net investment in lease and financing receivables, after allowance for credit loss, nonaccrual of $15.28M in Q1 2026.
How has Imax's net investment in lease and financing receivables, after allowance for credit loss, nonaccrual changed year-over-year?
Imax's net investment in lease and financing receivables, after allowance for credit loss, nonaccrual decreased by 24.3% year-over-year, from $20.19M to $15.28M.
What is the long-term trend for Imax's net investment in lease and financing receivables, after allowance for credit loss, nonaccrual?
Over 2 years (2023 to 2025), Imax's net investment in lease and financing receivables, after allowance for credit loss, nonaccrual has grown at a -13.4% compound annual growth rate (CAGR), from $20.32M to $15.22M.